Cardiology News and Research

Latest Cardiology News and Research

Phase I clinical study for ETC-1002 commenced

Esperion Therapeutics, a privately held biotechnology company working to discover, develop and commercialize treatments for cardiovascular and metabolic diseases, today announced that the company has initiated a Phase I clinical study for ETC-1002, the company's novel small molecule compound designed to beneficially regulate the levels of plasma lipids and lipoproteins.

16 Nov 2009

Health policy research round up - Medicare and Massachusetts

Robert Wood Johnson Foundation: The Secrets of Massachusetts' Success - "By the summer of 2008, less than two years after Massachusetts' health reform law became effective, only 2.6 percent of state residents were uninsured—the lowest proportion ever recorded for any state." This study by the RWJF-funded State Health Access Reform Evaluation (SHARE) initiative "explains how national reforms can use similar methods to avoid the pitfalls that have plagued other coverage expansions."

13 Nov 2009

Millar Instruments signs distribution partnership with Transonic Systems

Millar Instruments, Inc., developer and manufacturer of Mikro-Tip® pressure transducer catheters and pressure-volume (P-V) systems, and Transonic Systems, Inc., global leader in the design, manufacture and marketing of flow measurement devices, today announce a new distribution partnership.

13 Nov 2009

Study confirms that people with severe mental disorders more at risk of dying from heart disease

A large new study confirms that people with severe mental disorders — such as schizophrenia or other psychotic disorders — are 25 percent to 40 percent more prone to die from heart disease than people without mental illness are.

13 Nov 2009

Decreased heart functions associated with fat collection in different body locations: Study

Researchers from Boston University School of Medicine (BUSM) have shown that fat collection in different body locations, such as around the heart and the aorta and within the liver, are associated with certain decreased heart functions. The study, which appears on-line in Obesity, also found that measuring a person's body mass index (BMI) does not reliably predict the amount of undesired fat in and around these vital organs.

13 Nov 2009

M3 USA, Bristol-Myers Squibb to launch next-generation eLearning and eMarketing solution

M3 USA, together with Bristol-Myers Squibb, is launching a pilot program to oncologists using M3’s next-generation eLearning and eMarketing solution. The solution – M3 Messages™ – takes a new approach to developing valuable, long-term, online connections that help doctors stay current on advances in oncology.

13 Nov 2009

In rural Kentucky, an unexpected take on the health debate

Frank Browning reports for Kaiser Health News on how the health reform debate is playing out in rural Kentucky. "From a strip-mined bluff at the edge of this famous mountain town you can see one of the most concentrated and diverse sets of medical facilities in rural America: a general hospital, a psychiatric hospital, a university-based rural health care center and clinics for primary care, cancer, urology, cardiology, addiction and ear-nose-and throat problems.

13 Nov 2009

Study of GBHN Order Set project reveals improvements in the length of stay and ordering of best practices

A study of the Grey Bruce Health Network (GBHN) Order Set project has revealed impressive improvements in the length of stay and ordering of best practices.

13 Nov 2009

Millar Instruments and Harvard Apparatus announce a new distribution partnership

Millar Instruments, Inc. developer and manufacturer of Mikro-Tip® pressure transducer catheters and pressure-volume (P-V) systems and Harvard Apparatus, manufacturer of specialty life science equipment, today announced a new distribution partnership.

13 Nov 2009

First Edition: November 13, 2009

On this Friday the 13th, the headlines offer an array of health policy views -- from the possibility of including a Medicare payroll tax in health reform legislation to continuing analysis of the overhaul's winners and losers as well as the CDC's new estimate of the far-reach of the swine flu.

13 Nov 2009

Improved method of chest closure may set new standard of care for open-heart surgery

An innovative method is being used to repair the breastbone after it is intentionally broken to provide access to the heart during open-heart surgery. The technique uses a state-of-the-art adhesive that rapidly bonds to bone and accelerates the recovery process.

13 Nov 2009

Easy and affordable genetic test from Pathway Genomics

Pathway Genomics™ (www.PATHWAY.com), a privately held, venture-backed company, today announced an exclusive agreement to partner with OptumHealthSM Allies and offer the organization’s 15 million members a 20% discount on Pathway’s Health and Ancestry genetic test.

13 Nov 2009

Regence BlueCross recognized as Platinum-Level Start! Fit-Friendly Company

Regence BlueCross BlueShield has been recognized as a Platinum-Level Start! Fit-Friendly Company by the American Heart Association's Start! movement for helping employees eat better and move more.

13 Nov 2009

Nonprofit organizations receive a total of $4.6 million in grants from Edwards Lifesciences Fund

Edwards Lifesciences Corporation, the global leader in the science of heart valves and hemodynamic monitoring, today announced that The Edwards Lifesciences Fund is granting $1.8 million to 107 nonprofit organizations as part of its fifth annual grant cycle. This fund is a donor-advised fund of the Vanguard Charitable Endowment Program.

13 Nov 2009

New and effective medicines underway for treating a wide range of diseases affecting women

Women's Health Weekly recently reported that America's pharmaceutical research and biotechnology companies are working on nearly 1,000 life-changing medicines for diseases affecting women, according to a new report released by the Pharmaceutical Research and Manufacturers of America (PhRMA). The medicines are awaiting approval by the U.S. Food and Drug Administration or are in human clinical trials.

13 Nov 2009

Masked hypertension in CKD children can increase risk of heart disease

Many children with chronic kidney disease (CKD) who show normal blood pressure readings at the doctor's office have high blood pressure when tested at home, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN).

13 Nov 2009

Changes in CMS reimbursement to accelerate demand for cardiac PET imaging

Positron Corporation a molecular imaging solutions company focused on Nuclear Cardiology, expects the evolution from cardiac SPECT to cardiac PET imaging will be greatly accelerated with the recent changes in reimbursement from the Centers for Medicare & Medicaid Services (CMS) set for 2010.

13 Nov 2009

Cardiac Science and Cambridge Heart team up to develop MTWA module

Cardiac Science Corporation [NASDAQ: CSCX], a global leader in automated external defibrillator (AED) and diagnostic cardiac monitoring devices, and Cambridge Heart, Inc., [OTCBB-CAMH], a developer of noninvasive diagnostic tests for cardiac disease, with a focus on identifying those at risk for sudden cardiac arrest, today announced a partnership pursuant to a Development, Supply and Distribution Agreement Cambridge Heart previously announced on June 23, 2009.

13 Nov 2009

LA BioMed to participate in a national study of the effectiveness of testosterone

Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) announced today that it will participate in a large national study of the effectiveness of testosterone as a treatment for anemia, cardiovascular disease, decreased vitality, impaired memory and sexual function, loss of muscle mass and other health conditions that affect older men.

13 Nov 2009

Results from first-in-man study of NO-donating HMG-CoA Reductase Inhibitor released

NicOx S.A. today announced that a phase 1b, first-in-man study for NCX 6560, versus placebo and Lipitor® (atorvastatin), has met its primary and secondary objectives. The top-line results demonstrated very good safety and tolerability for all the tested doses of NCX 6560, as well as the expected cholesterol lowering profile.

13 Nov 2009

Cardiology News and Research

Latest Cardiology News and Research

Phase I clinical study for ETC-1002 commenced

Health policy research round up - Medicare and Massachusetts

Millar Instruments signs distribution partnership with Transonic Systems

Study confirms that people with severe mental disorders more at risk of dying from heart disease

Decreased heart functions associated with fat collection in different body locations: Study

M3 USA, Bristol-Myers Squibb to launch next-generation eLearning and eMarketing solution

In rural Kentucky, an unexpected take on the health debate

Study of GBHN Order Set project reveals improvements in the length of stay and ordering of best practices

Millar Instruments and Harvard Apparatus announce a new distribution partnership

First Edition: November 13, 2009

Improved method of chest closure may set new standard of care for open-heart surgery

Easy and affordable genetic test from Pathway Genomics

Regence BlueCross recognized as Platinum-Level Start! Fit-Friendly Company

Nonprofit organizations receive a total of $4.6 million in grants from Edwards Lifesciences Fund

New and effective medicines underway for treating a wide range of diseases affecting women

Masked hypertension in CKD children can increase risk of heart disease

Changes in CMS reimbursement to accelerate demand for cardiac PET imaging

Cardiac Science and Cambridge Heart team up to develop MTWA module

LA BioMed to participate in a national study of the effectiveness of testosterone

Results from first-in-man study of NO-donating HMG-CoA Reductase Inhibitor released

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Cardiology News and Research

Latest Cardiology News and Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Newsletters you may be interested in